Next 10 |
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
2024-07-29 20:40:19 ET Hologic, Inc. (HOLX) Q3 2024 Earnings Conference Call July 29, 2024 04:30 ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President & CEO Essex Mitchell - COO Karleen Oberton - CFO Conference Call Par...
2024-07-29 16:05:28 ET More on Hologic Hologic: Women's Health Play Looks Healthier Itself Hologic, Inc. (HOLX) Q2 2024 Earnings Call Transcript Hologic Q3 2024 Earnings Preview Hologic’s recall of BioZorb Markers classified as FDA’s most seriou...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Endomagnetics Ltd (Endomag), a privately held UK-based developer of breast cancer surgery technologies, for approximately $310 million. This press release features mul...
New Survey Reveals Women Struggle to Prioritize Their Health Millions of women in the United States have missed screenings for serious, often life-threatening conditions, according to a new survey released today by women’s health innovator Hologic, Inc. (Nasdaq: HOLX). This p...
2024-07-02 09:00:08 ET Vijay Kumar from Evercore ISI issued a price target of $76.00 for HOLX on 2024-07-02 08:04:00. The adjusted price target was set to $76.00. At the time of the announcement, HOLX was trading at $74.1. The overall price target consensus is at $78.33 ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2024 on Monday, July 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. In...
2024-06-27 10:25:17 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sports betting is a huge, rapidly growing business in the U.S. According to Statista , the revenue of the U.S. online sports betting market reached about $19 billion in 2023, up from ro...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...